FIELD: medicine.
SUBSTANCE: invention can be used at the infiltrates caused by introduction of a hyperosmotic solution of a medical product in a tissue. For this purpose localisation and the size of an infiltrate are defined immediately, a needle is left in the place of injection. The method further includes defining an indicator of osmotic activity and volume of the solution ingected; detaching a needle from a syringe and injecting a water for injection cooled to 0°C into tissues with the second syringe in the volume providing normalisation of osmotic pressure of the solution injected with the subsequent applying of a bubble with ice for not less than 30 minutes. As first, half of the volume is injected in the form of consecutive injections on peripheries of the infiltrate formed, the other half of the volume being injected, through the needle left, into its central part.
EFFECT: method allows for preventing development of postinjection necrosis before an irreversible stage of inflammation thanks to depression of size of osmotic pressure of hyperosmotic agent injected.
1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD INCREASING SAFETY OF INJECTIONS | 2007 |
|
RU2340361C1 |
RAPID ASSESSMENT OF POSTINJECTION LOCAL DRUG TOXICITY LEVEL | 2007 |
|
RU2367946C1 |
METHOD FOR SKIN DISCOLORATION IN BRUISING AREA | 2015 |
|
RU2586278C1 |
METHOD OF POSTINJECTION NECROSIS PREVENTION | 2006 |
|
RU2326662C1 |
METHOD OF INCREASING POSTINJECTION SAFETY OF MEDICINES AT REPEATED INTRAMUSCULAR INJECTIONS | 2007 |
|
RU2350358C2 |
METHOD FOR VACCINE INJECTION | 2006 |
|
RU2342156C2 |
METHOD FOR PREVENTING POST-INJECTION NECROSIS | 2004 |
|
RU2277415C1 |
BLEACHING AGENT | 2014 |
|
RU2589682C1 |
METHOD OF FUNICULAR ANESTHESIA | 2010 |
|
RU2422164C1 |
SOFT TISSUE INJECTION METHOD | 2007 |
|
RU2328318C1 |
Authors
Dates
2008-09-10—Published
2007-02-26—Filed